Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
21.24
-0.34 (-1.58%)
Nov 18, 2026, 3:04 PM CST

SHE:300357 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
11,12114,84410,63915,18428,84930,001
Market Cap Growth
-36.88%39.52%-29.93%-47.37%-3.84%-25.29%
Enterprise Value
9,68213,6179,54714,16027,83929,137
Last Close Price
21.5828.0719.9028.1453.1555.02

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
26.0238.9733.4848.9582.7288.76
Forward PE
24.9533.3526.8038.4162.0969.52
PS Ratio
10.0113.9711.5017.9032.2037.15
PB Ratio
3.825.474.336.5914.2316.70
P/TBV Ratio
3.986.014.867.5015.6818.27
P/FCF Ratio
27.5554.7979.9298.21180.74126.95
P/OCF Ratio
23.2935.0840.5439.7480.0883.20

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
EV/Sales Ratio
8.7312.8210.3216.7031.0736.07
EV/EBITDA Ratio
19.6229.9226.4541.8569.1879.58
EV/EBIT Ratio
22.3233.5930.0846.1372.8684.20
EV/FCF Ratio
24.0150.2671.7291.59174.41123.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Debt / Equity Ratio
0.000.010.010.030.010.00
Debt / EBITDA Ratio
0.020.040.070.180.040.02
Debt / FCF Ratio
0.030.070.190.400.100.03
Net Debt / Equity Ratio
-0.50-0.52-0.52-0.53-0.55-0.56
Net Debt / EBITDA Ratio
-3.09-3.11-3.57-3.62-2.78-2.77
Net Debt / FCF Ratio
-3.74-5.22-9.68-7.93-7.01-4.29
Asset Turnover
0.370.380.350.360.430.46
Inventory Turnover
1.050.900.770.750.830.68
Quick Ratio
11.7611.638.618.4313.7211.76
Current Ratio
12.1112.189.058.8714.3812.42
Return on Equity (ROE)
14.50%14.24%12.78%13.65%17.56%19.63%
Return on Assets (ROA)
8.95%9.04%7.53%8.06%11.56%12.23%
Return on Invested Capital (ROIC)
25.92%27.95%23.55%26.42%38.04%40.44%
Return on Capital Employed (ROCE)
14.30%14.70%12.60%12.90%18.20%19.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Earnings Yield
3.84%2.57%2.99%2.04%1.21%1.13%
FCF Yield
3.63%1.82%1.25%1.02%0.55%0.79%
Dividend Yield
1.18%0.88%1.08%0.64%0.36%0.35%
Payout Ratio
30.68%30.27%30.66%34.05%30.17%24.79%
Buyback Yield / Dilution
-0.00%0.01%0.00%0.00%0.00%-0.00%
Total Shareholder Return
1.17%0.89%1.08%0.64%0.36%0.35%